Skip to content

Milestones

February 2011
Company formation
February 2011
May 2017
Series A financing
May 2017
September 2018
Convertible note financing
September 2018
August 2019
Convertible note financing
August 2019
October 2019
Australian regulatory approval for Phase 1 study in patients with retinal detachment
October 2019
Version 2
October 2019
First patient dosed, first in human clinical trial in retinal detachment
October 2019
December 2019
ONL1204 patent issued in US
December 2019